Okamura DM - Search Results

1

Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease.

Okamura DM, Himmelfarb J. Okamura DM, et al. Pediatr Nephrol. 2009 Dec;24(12):2309-19. doi: 10.1007/s00467-009-1199-5. Epub 2009 May 7. Pediatr Nephrol. 2009. PMID: 19421784 Review.

2

CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD.

Okamura DM, Pennathur S, Pasichnyk K, López-Guisa JM, Collins S, Febbraio M, Heinecke J, Eddy AA. Okamura DM, et al. J Am Soc Nephrol. 2009 Mar;20(3):495-505. doi: 10.1681/ASN.2008010009. Epub 2009 Feb 11. J Am Soc Nephrol. 2009. PMID: 19211715 Free PMC article.

3

Investigating mechanisms of chronic kidney disease in mouse models.

Eddy AA, López-Guisa JM, Okamura DM, Yamaguchi I. Eddy AA, et al. Among authors: okamura dm. Pediatr Nephrol. 2012 Aug;27(8):1233-47. doi: 10.1007/s00467-011-1938-2. Epub 2011 Jun 22. Pediatr Nephrol. 2012. PMID: 21695449 Free PMC article. Review.

4

Cysteamine modulates oxidative stress and blocks myofibroblast activity in CKD.

Okamura DM, Bahrami NM, Ren S, Pasichnyk K, Williams JM, Gangoiti JA, Lopez-Guisa JM, Yamaguchi I, Barshop BA, Duffield JS, Eddy AA. Okamura DM, et al. J Am Soc Nephrol. 2014 Jan;25(1):43-54. doi: 10.1681/ASN.2012090962. Epub 2013 Sep 5. J Am Soc Nephrol. 2014. PMID: 24009239 Free PMC article.

5

The macrophage phagocytic receptor CD36 promotes fibrogenic pathways on removal of apoptotic cells during chronic kidney injury.

Pennathur S, Pasichnyk K, Bahrami NM, Zeng L, Febbraio M, Yamaguchi I, Okamura DM. Pennathur S, et al. Among authors: okamura dm. Am J Pathol. 2015 Aug;185(8):2232-45. doi: 10.1016/j.ajpath.2015.04.016. Epub 2015 Jun 16. Am J Pathol. 2015. PMID: 26092500 Free PMC article.

6

The balance of powers: Redox regulation of fibrogenic pathways in kidney injury.

Okamura DM, Pennathur S. Okamura DM, et al. Redox Biol. 2015 Dec;6:495-504. doi: 10.1016/j.redox.2015.09.039. Epub 2015 Sep 26. Redox Biol. 2015. PMID: 26448394 Free PMC article. Review.

7

Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury.

Okamura DM, López-Guisa JM, Koelsch K, Collins S, Eddy AA. Okamura DM, et al. Am J Physiol Renal Physiol. 2007 Aug;293(2):F575-85. doi: 10.1152/ajprenal.00063.2007. Epub 2007 May 30. Am J Physiol Renal Physiol. 2007. PMID: 17537985 Free article.

8

CD36 in chronic kidney disease: novel insights and therapeutic opportunities.

Yang X, Okamura DM, Lu X, Chen Y, Moorhead J, Varghese Z, Ruan XZ. Yang X, et al. Among authors: okamura dm. Nat Rev Nephrol. 2017 Dec;13(12):769-781. doi: 10.1038/nrneph.2017.126. Epub 2017 Sep 18. Nat Rev Nephrol. 2017. PMID: 28919632 Free article. Review.

9

LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.

Shah L, Hooper DK, Okamura D, Wallace D, Moodalbail D, Gluck C, Koziell A, Zaritsky JJ. Shah L, et al. Pediatr Nephrol. 2019 Nov;34(11):2343-2350. doi: 10.1007/s00467-019-04296-6. Epub 2019 Jun 27. Pediatr Nephrol. 2019. PMID: 31250206

10

Utility of the 2018 revised ISN/RPS thresholds for glomerular crescents in childhood-onset lupus nephritis: a Pediatric Nephrology Research Consortium study.

Patel P, de Guzman M, Hicks MJ, Maliakkal JG, Rheault MN, Selewski DT, Twombley K, Misurac JM, Tran CL, Constantinescu AR, Onder AM, Seamon M, Seeherunvong W, Singh V, Pan C, Okamura DM, Omoloja A, Kallash M, Smoyer WE, Hidalgo G, Wenderfer SE. Patel P, et al. Among authors: okamura dm. Pediatr Nephrol. 2022 Dec;37(12):3139-3145. doi: 10.1007/s00467-022-05524-2. Epub 2022 Mar 28. Pediatr Nephrol. 2022. PMID: 35347402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page